Photoacoustic Imaging in Gastroenterology: Advances and Needs by Bhushan, Sheena et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books
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Gastroenterologists routinely use optical imaging and ultrasound for the 
minimally invasive diagnosis and treatment of chronic inflammatory diseases and 
cancerous tumors in gastrointestinal tract and related organs. Recent advances in 
gastroenterological photoacoustics represent combination of multispectral and 
multiscale photoacoustic (PA), ultrasound (US), and near-infrared (NIR) fluores-
cent imaging. The novel PA endoscopic methods have been evaluated in preclini-
cal models using catheter-based miniature probes either noncontact, all-optical, 
forward-viewing probe or contact, side-viewing probe combined with ultrasound 
(esophagus and colon). The deep-tissue PA tomography has been applied to 
preclinical research on targeted contrast agents (pancreatic cancer) using bench-
top experimental setups. The clinical studies engaging human tissue ex vivo have 
been performed on endoscopic mucosal resection tissue with PA-US tomography 
system and intraoperative imaging of pancreatic tissue with PA and NIR fluores-
cence multimodality. These emerging PA methods are very promising for early 
cancer detection and prospective theranostics. The noninvasive transabdominal 
examination with PA-US handheld probe has been implemented into clinical trials 
for the assessment of inflammatory bowel disease. To facilitate translational and 
clinical research in PA imaging in gastroenterology, we discuss potential clinical 
impact and limitations of the proposed solutions and future needs.
Keywords: photoacoustic endoscopy, optoacoustic tomography,  
gastrointestinal tract, Barrett’s esophagus, intraoperative, pancreatic cancer, 
inflammatory bowel disease
1. Introduction
Gastroenterology is a field of medicine that studies the gastrointestinal (GI) 
tract and its disorders. The GI tract consists of the mouth, pharynx, esophagus, 
stomach, small intestine (duodenum, jejunum, ileum), large intestine (also called 
colon which consists of the cecum, rectum, and anal canal), appendix, liver, and 
pancreas [1]. Imaging techniques used for the diagnosis and treatment of gastro-
intestinal disorders mainly include noninvasive methods (such as whole body and 
transabdominal imaging), minimally invasive methods (such as endoscopy), and 
invasive methods (such as intraoperative imaging) (Figure 1).
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The word endoscopy is derived from the Greek words endo (within) and 
skopein (to see). Endoscopy is a medical procedure that employs a medical instru-
ment called the endoscope, which is inserted directly into an organ or cavity (e.g., 
esophagus), thereby allowing a gastroenterologist to visualize and examine the 
organ’s interior. Organs and cavities of the gastrointestinal tract that can be visual-
ized and examined by endoscopy include (i) the esophagus, stomach, and duode-
num (esophagogastroduodenoscopy); (ii) the small intestine (enteroscopy);  
(iii) the large intestine (colonoscopy, sigmoidoscopy); (iv) the bile duct and pan-
creas (endoscopic retrograde cholangiopancreatography, also known as ERCP); and 
(v) the rectum (rectoscopy) and anus (anoscopy); when both the rectum and anus 
are examined together, the procedure is called proctoscopy [2].
As a clinical specialty, gastroenterology relies upon endoscopy mainly for the 
following purposes:
a. To detect pathologies like ulcers, varices, inflammation, and bleeding—which 
are not visible to the naked eye.
b. To confirm diagnosis of cancers by taking biopsies.
c. To treat pathologies in a minimally invasive manner. For example, treating a 
bleeding vessel by cauterization, a narrow esophagus by widening (endoscopic 
dilation), polyps and foreign bodies by removal, and varices by banding.
Gastrointestinal endoscopy is continually evolving to enable early detec-
tion of diseases, which can significantly impact treatment outcomes. The best-
known endoscopic imaging methods in practice are (1) white light endoscopy, 
(2) narrowband imaging, (3) optical coherence tomography, (4) confocal laser 
endomicroscopy, and (5) endoscopic ultrasound. In this section, we will discuss 
these endoscopic imaging techniques and highlight their main advantages and 
limitations.
Figure 1. 
Diagram of imaging modalities applied in gastroenterology: CT, computed tomography; MRI, magnetic 
resonance imaging; US, ultrasound imaging; PA, photoacoustic imaging; WLE, white light endoscopy; 
NBI, narrowband imaging; PAE, photoacoustic endoscopy; OCT, optical coherence tomography; CLE, 
confocal laser endomicroscopy; EUS, endoscopic ultrasound; IOUS, intraoperative ultrasound; NIR, 
near-infrared.
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1.1 White light endoscopy
White light endoscopy (WLE) is the most commonly used endoscopic imaging 
modality. WLE applies the full spectrum of visible white light (400–700 nm) to 
visualize the outermost lining of the GI tract (also called the mucosa or epithelium) 
[3]. Xenon lamps are used to produce white light, which is transmitted through a 
filter and then reflected by the mucosa. A CCD camera then processes the reflected 
light to an image monitor. The image can either be of a standard resolution or can be 
magnified up to 150 times in the more recent versions [4]. WLE detects slight color 
changes on the mucosa (slight redness and pallor). However, it is incredibly chal-
lenging to detect early cancer; as in early stages, the lesion is usually unremarkable, 
with no significant color changes. Furthermore, WLE is limited by what the human 
eye can see and is often associated with low sensitivity for the detection of early 
neoplasia. Consequently, in attempts to increase the sensitivity of WLE, chromo-
endoscopy is often added. Chromoendoscopy is a technique in which special stains 
are topically applied to the mucosa during endoscopy. Chromoendoscopy highlights 
subtle irregularities in the mucosa [5], and while it can help the gastroenterologist 
uncover some lesions invisible to the naked eye, the specificity is often quite low.
1.2 Narrowband imaging
Narrowband imaging (NBI) is one of the most widely available optical imaging 
techniques today. In addition to highlighting subtle differences in the epithelium 
(like the combination of WLE and chromoendoscopy does), NBI can also highlight 
changes to the subsurface mucosal vascularization, without the use of any special 
stains or dyes. It can be activated by pressing a button on the endoscope, and once 
activated it uses special filters to narrow the wavelength range of the emitted light 
into blue (400–430 nm; centered at 415 nm) and green light (525–555 nm; centered 
at 540 nm) [6]. This system exploits the principle of depth of light penetration 
in accordance with the Beer-Lambert law: the shorter the wavelength, the more 
superficial the penetration. The blue filter is designed to coincide with the peak 
absorption spectrum of hemoglobin, and it enhances the mucosal vasculature, 
like capillaries, which appear brown under NBI. The green light penetrates deeper 
and enhances the appearance of submucosal vasculature, like veins, which appear 
cyan [7]. Computer processing can further enhance the images. Since increased 
vasculature is one of the earliest signs associated with cancer, NBI helps with the 
detection of early cancer. By helping the gastroenterologist visualize and differenti-
ate abnormal cancer margins from normal healthy tissue, it also helps determine the 
mucosal areas that should be biopsied. However, NBI is not able to image submuco-
sal abnormalities.
1.3 Confocal laser endomicroscopy
The term confocal refers to the alignment of both illumination and collection 
systems in the same focal plane. Confocal laser endomicroscopy (CLE) focuses blue 
laser light (488 nm) through a single lens on to a specific target, with subsequent 
detection of the fluorophores (excitable using 488 nm laser light) in the tissue 
through a pinhole [8]. Typically, endomicroscopes have a miniaturized scanning 
head at the tip of the endoscope or execute the scanning outside the patient transfer-
ring the scan pattern of the tissue through an optical fiber bundle. CLE can provide 
high-resolution images (~0.7–1 μm) of the GI mucosa at a cellular and subcellular 
level, with a field of view of ~200–300 μm [9]. By delivering real-time surrogate 
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“optical biopsies,” it enables physicians to interpret histology in real time. Since the 
first visible neoplastic changes in epithelial cancers occur at a cellular level (such 
as increased nucleocytoplasmic ration, irregular shape and size of the nucleus, 
fragmentation of nucleus, prominent nucleoli, etc.), it facilitates early detection and 
treatment of cancer. It allows for targeted biopsies of abnormal mucosa, thereby 
decreasing unnecessary biopsy as compared to WLE. Besides the esophagus and 
colon, it is also able to provide an optical biopsy within the pancreas [10]. Since 
CLE relies upon tissue fluorescence, intravenous or topically applied contrast agents 
(dyes) are required [11]. The major disadvantage of CLE is a small field of view 
(<1 mm) when compared to the area of examined surfaces (several cm).
1.4 Optical coherence tomography
Optical coherence tomography (OCT), also known as volumetric laser endo-
microscopy (VLE), is a more recent endoscopic imaging technique. OCT is based 
on the same echolocation principle as an ultrasound but uses light waves instead 
of acoustic waves [12]. The OCT imager’s probe can be introduced through the 
accessory channel of an endoscope and be directed toward the area of interest. It 
is then kept in contact with the mucosal surface. OCT uses near-infrared (NIR) 
light (700–1500 nm range of wavelength) and directs it at the target tissue. Using 
an interferometer device setup, the differential light scatter is picked up, inter-
preted, and converted into a cross-sectional image. The typical axial resolution is 
around 7–10 μm which enables the cross-sectional images to provide information 
about the architectural morphology of the GI epithelium at a microscopic level. 
The lateral resolution of OCT is about 30 μm, and depending on the applied 
wavelength of light, depth of penetration for OCT is around 2–3 mm [13]. Since 
tissue is relatively transparent, the longer wavelength can penetrate deeper than 
CLE. However, the lateral resolution is lower than that of CLE (CLE resolution 
is up to 1 μm). While OCT resolution is able to detect deeper structures (e.g., 
crypts and glands), it cannot pick up microscopic nuclear changes, such as 
nuclear dysplasia. The main advantage of OCT is the deeper penetration, which 
would help detect cancer in the submucosal layer (the layer present right below 
the mucosa) [14]. On the other hand, clinical interpretation of OCT images can 
be challenging.
1.5 Endoscopic ultrasound
Endoscopic ultrasound (EUS) can differentiate between the various layers of the 
gastrointestinal tract and provide anatomical and structural details. It can employ 
a broad range of frequencies (5–20 MHz) to provide images with a variable depth 
of penetration (5–6 to 1–2 cm) and resolution (2–3 to ~0.2 mm) [15]. The most 
routinely used EUS array has a central frequency of 7.5 MHz. EUS is limited by a 
lack of specificity and an inability to differentiate between pathologies due to poor 
contrast (for example pancreatitis from pancreatic cancer) and is of limited use in 
picking up early and metastatic cancer. Additionally, EUS is a technique that largely 
depends on the operator’s skills and has a significantly long learning curve for 
novice gastroenterologists [16].
The aforementioned imaging techniques have come a long way since their incep-
tion, but are still far from perfect in several ways. Imaging that relies on WLE is 
substantially limited by what the human eye can see and detect on the surface, with 
no insight into the subsurface or cellular level. Techniques like NBI and CLE are able 
to provide a higher resolution but cannot reach superior depths of penetration. OCT 
and EUS can penetrate deeper into the tissue but are limited by poor contrast, which 
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makes interpretation of pathology difficult especially for early detection. Therefore, 
they are usually associated with low sensitivity and specificity. Figure 2 summa-
rizes the aforementioned optical methods of endoscopy.
The field of endoscopic imaging is continuously being upgraded in an attempt 
to address some of the abovementioned concerns. An emerging imaging technique 
known as photoacoustics (PA) may have a major advantage over other imaging 
modalities in both resolution and penetration depth.
1.6 Photoacoustic imaging
The basic principle of photoacoustic (aka optoacoustics) imaging is derived 
from the photoacoustic effect: (1) it uses a pulsed nanosecond-long laser light 
to illuminate a target tissue, and (2) when the energy of laser light is rapidly 
absorbed and followed by fast heating of material, it is converted into pressure 
wave via thermoelastic expansion of the targeted tissue. Using detected acoustic 
signals, the PA images can be reconstructed by means of algorithms of computed 
tomography (CT).
The amplitude of a generated PA pressure wave, p, can be described by the 
formula [17, 18]:
  p =  μ a F Γ =  μ a F  
β  V l 
2 
 ____
 C p 
 , (1)
with the optical absorption coefficient μa, the local optical fluence F, and  
the dimensionless Grüneisen parameter Γ representing thermoelastic efficiency of 
the medium. The Grüneisen parameter is temperature sensitive and depends on the 
volumetric thermal expansion coefficient (β), the speed of sound (Vl) for longitu-
dinal waves, and the specific heat capacity at constant pressure (Cp) [19, 20]. In the 
tissue, a rise of temperature ΔT ~ 10−3°C generates a pressure wave of p ~ 1 kPa.
The depth of imaging is correlated with (a) the depth of light penetration in 
materials and (b) the detection sensitivity of an US transducer that varies with its 
frequency range. Since PA imaging combines the use of light and sound, it can pro-
vide spatial resolution at the scale of optical imaging (up to submillimeter range) 
and a penetration depth across US dimensions (at centimeter range).
Figure 2. 
Comparison of endoscopic imaging modalities: (a) WLE, (b) NBI, (c) CLE, and (d) OCT. (a–c) Images by 
Prof. Sharmila Anandasabapathy, MD. (d) Image courtesy of Prof. Guillermo J. Tearney, MD, PhD.
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Resolution of PA images can be affected by multiple factors. Heat-generating 
optical energy must be delivered to the tissue faster than the producing pressure 
wave can propagate the distance equal to the desired spatial resolution. Therefore, 
the use of nanosecond optical pulses is a necessary (but not sufficient) condition to 
achieve the desirable spatial resolution. Besides, a temporal response function of a 
pressure-wave detector has to be not slower than the optical-pulse duration to make 
sure that the desirable spatial resolution is achievable.
Tissue structure can be represented by PA images only if acoustic detectors are 
capable to resolve rapid changes in PA signals associated with boundaries and sharp 
edges in tissues and reproduce slow changes associated with smooth variation in 
optical properties within the tissue at once. That is to say, acoustic detectors must 
register both high and low ultrasonic frequencies of acoustic pressure at the same 
time. Such acoustic detectors are called ultra-wideband acoustic transducers [18, 21].
It is challenging to detect PA signal properly. The US detection bandwidth of an 
acoustic transducer defines the limits of axial (depth) resolution. Furthermore, the 
lateral resolution of PA images is provided by an array of transducers and depends 
on the dimensions of each acoustic transducer and the geometry and dimensions 
and of the US transducers in an array. Scanning a single transducer along tissue 
surface can simulate the array.
In practice, PA imaging is frequently combined with conventional US detectors. 
At the same time, conventional US detectors have relatively narrowband character-
istics due to its design to both transmit and receive acoustic wave. Spectral ampli-
tudes of typical PA signal and US transducer parameters are illustrated on Figure 3.
Conventional piezoelectric transducers limit the potential axial resolution of 
broadband PA signals. Note that all-optical detectors of PA signal are wideband and 
have significant advantage in these terms [22, 23].
In general, the depth-resolution ratio defines the quality of PA imaging system. 
The tradeoff between depth and resolution leads to three types of PA imaging 
methods: microscopy (μm-scale, cellular), mesoscopy (mm-scale, microvascula-
ture), and macroscopy (cm-scale, organs).
Scanning PA microscopy can demonstrate resolutions greater than 50 μm (e.g., 
resolving capillary bed and even single erythrocytes) [24] at depths that are beyond 
the optical diffusion limit, something which is not achievable with conventional 
microscopy methods (depths are up to 4–5 mm). Additionally, spatial resolution 
and penetration depth are somewhat mutually exclusive in imaging techniques like 
the ultrasound (i.e., as the penetration depth increases, spatial resolution decreases 
and vice versa). PA imaging in gastroenterology mostly employs meso- and 
Figure 3. 
Spectral amplitudes of broadband PA signal and conventional US transducer.
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macroscopic scale. PA deep-tissue imaging uses NIR light to generate an acoustic 
signal allowing for more clinically relevant penetration depth up to several centi-
meters, along with maintenance of spatial resolution (resolution of 0.2–2 mm at 
reported imaging depths of 3–7 cm) [18]. Combining clinically relevant depth with 
high resolution can make it possible to unmask inconspicuous “flat” lesions during 
early stages of cancer development. It can also help with determining the extent of 
the tumor depth both intraoperatively and postoperatively. Figure 4 resumes the 
depth of penetration associated with the aforementioned imaging modalities on the 
example of the esophageal lining tissue.
Unlike other imaging modalities, PAI can use endogenous chromophores such 
as oxyhemoglobin, deoxyhemoglobin, lipid, water, and melanin. The NIR light 
has longer wavelengths (700–1000 nm) than the visible light range, and these 
wavelengths can be used to reach deep within the tissue and provide detailed 
information about its composition. In addition to revealing normal physiological 
characteristics (total hemoglobin concentration, O2 saturation of hemoglobin, blood 
flow, temperature), it can help physicians detect hypoxia, perfusion, and increased 
vasculature (also called neoangiogenesis—which is an early sign of cancer) through 
anatomical and functional imaging, relying exclusively on endogenous contrast agent 
(without dyes). Exogenous agents can also be used to provide molecular imaging, 
to enhance the contrast further, and to facilitate deeper penetration. They can be 
used in a targeted manner to target molecular-specific processes, such as biomarkers 
specific to inflammation or certain type of tumors. For example, cancer develop-
ment is associated with increased permeability of the vasculature, which leads to 
extravasation of the contrast agent use. Overall, by providing a high optical contrast, 
it helps differentiate the cancer margin from the surrounding healthy tissue in real 
time. Lastly, it is quite similar and also naturally compatible with the ultrasound in 
Figure 4. 
Schematic summarizing the depths of penetration into esophagus tissue for routine and emerging imaging 
techniques.
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principle and operation. It is portable and can be used in real time and requires no 
special training. It does not utilize ionizing radiations and is therefore minimally 
invasive and safe, making it an easily adoptable technology for physicians. In the 
upcoming sections of this chapter, we will discuss most recent PA imaging applica-
tions for gastroenterology.
2. Applications of photoacoustic imaging in endoscopy
2.1 Esophageal cancer
Esophageal adenocarcinoma carries a significant disease burden in the Western 
world. Barrett’s esophagus (BE) is the most important risk factor for developing 
esophageal adenocarcinoma. Patients with BE are at 30- to 125-fold increased 
risk of developing cancer than the general population [25]. Patients who develop 
high-grade dysplasia (HGD) from BE have an even higher chance of developing 
esophageal adenocarcinoma [26]. Indeed, early detection of Barrett’s esophagus sig-
nificantly improves treatment outcomes, yet accurate detection of dysplasia in BE 
still remains a challenge. In BE, the normal esophageal squamous mucosa (which 
appears white under WLE) is replaced by an intestinal-type columnar mucosa 
(appears salmon pink under WLE). The current standard of care includes taking 
targeted biopsies of visible lesions under WLE guidance, which are then sent over to 
histopathology for staging. However, since this approach cannot sample the entire 
esophagus, the chances of missing dysplasia (precursor to cancer) are very high 
[27]. Additionally, the screening is just limited to the mucosa, making detection of 
submucosal invasion impossible.
Indeed, techniques like NBI and CLE yield high-contrast, subcellular images, 
but they fall short in terms of depth (1.5–2 mm) [28], which is not sufficient to 
detect submucosal invasion. Tumors that have invaded the submucosa are treated 
by surgical removal of the esophagus (esophagectomy) which is often associated 
with significant mortality and decreased quality of life, whereas tumors that have 
not yet invaded the submucosa can be treated by less aggressive techniques like 
endoscopic mucosal resection (EMR). There is a clinical need for developing an 
imaging modality that can detect dysplasia in vivo and also image beyond the 
mucosa layer into the submucosa. Since PA microscopy can provide high-resolution 
imaging of the microvasculature, it can help to bridge these gaps by helping 
physicians to differentiate between nondysplastic and dysplastic BE early on. 
Additionally, it is also capable of imaging deeper into the tissue (up to 3–5 mm) and 
reaching the submucosal layer, thereby also helping with staging of the cancer in 
real time. In the next section of this chapter, we will talk about an in vivo preclinical 
and an ex vivo clinical study that used PAI to help detect esophageal cancer.
2.1.1 Noncontact, all-optical photoacoustic endoscopy
A miniature, all-optical, forward-viewing PA catheter for high-resolution 3D 
endoscopy was developed by Ansari et al. [29]. The sensor provided the necessary 
broadband (1–70 MHz), well-behaved frequency response for faithfully recording 
the wideband acoustic frequency spectrum of photoacoustic waves. A 3D image had 
a cylindrical field of view of 3.5 × 7 mm; the diameter of the catheter was 3.2 mm. 
The lateral resolution ranged from 40 μm at a depth of 1 mm to 175 μm at a depth 
of 7 mm. These variations arise because the solid angle that is subtended by the 
absorbers to the FP sensor plane decreases as the depth increases. The first tests 
were performed on highly vascularized tissue samples and demonstrated great 
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potential of the method (Figure 5). Excitation laser wavelength, 590 nm; pulse 
repetition frequency, 30 Hz; and incident fluence, 15 mJ/cm2, which is lower than 
the American National Standards Institute (ANSI) laser safety limit (20 mJ/cm2), 
were used.
The microvasculature can be seen very well. The data acquisition time was as 
long as 25 min and cannot be considered as clinically relevant; though, in the future 
this parameter can be improved applying a faster laser with pulse repetition rate up 
to 200 Hz and parallelizing readout of the sensor. The technique described above 
addressed some of the needs for early diagnostics of esophageal cancer (since BE 
is associated with increased vasculature) and demonstrate capability to image 
partially submucosa. However, to the best of our knowledge, no examination of this 
method was performed on esophagus so far either in vivo or ex vivo.
2.1.2 Catheter-based photoacoustic ultrasound endoscopy
The use of contact (coupling required) multimodal photoacoustic and ultrasonic 
endoscopic imaging to two rabbit esophagi, to investigate the esophageal lumen 
structure and microvasculature, was demonstrated by Yang et al. [30]. Both in vivo 
and ex vivo studies were performed, and high-resolution photoacoustic images of 
vasculature network in the walls of GI tract were acquired and analyzed. To per-
form this experiment, they used a catheter-like side-viewing photoacoustic endo-
scope/endoscope ultrasound miniprobe (PAE-EU). This setup allowed to image 
internal walls of the GI tract using both PA and US simultaneously. A wavelength of 
584 nm with a laser energy of 0.3 mJ/pulse was used to produce PA image contrast 
proportional to the hemoglobin concentration. The detection transducer was fabri-
cated as ~36 MHz, 65% fractional bandwidth that allowed a penetration depth of up 
to 3.5 mm. The field of view of the endoscopic scanning system was 7 mm, and its 
angular field of view was set to 270 degrees. A focused US transducer detected 1D 
depth-resolved signals (or A-lines), and cross-sectional images (or B-scans) were 
produced using rotation of a scanning mirror that directed optical and acoustic 
waves. Data acquisition system collected dual-wavelength photoacoustic and 
Figure 5. 
(A) Schematic of the all-optical forward-viewing PA endoscopy probe includes the magnified distal end of 
individual fiber-optic cores in the coherent fiber bundle and ultrasound sensor based on the principle of fabry-
perot (FP) interferometer. (B) High-resolution PA images of ex vivo capillary network of the chorioallantoic 
membrane that surrounds the avian embryo. X-Y maximum intensity projections (MIPs) for depth range  
z = 0–200 μm of two regions on the same sample with the microvascular anatomy. (C) X-Y MIPs for the depth 
range z = 0–1.5 mm for the same two regions as Panel B, respectively, and Y-Z MIPs. The images are reproduced 
from open-source publication [29] with author permission.
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ultrasonic B-scan images in real time (~4 Hz) during the experimental procedure. 
The endoscopic probe had a diameter of 3.8 mm and a working distance of 0.5 mm 
from the probe surface which were optimal for a rabbit esophagi. The recently 
upgraded version has diameter of 3.2 mm and fits within the 3.7 mm diameter of 
instrument channel of a standard clinical video endoscope (Figure 6).
Two intact rabbit esophagi were imaged using the above setup. The rabbits 
were fasted for 12 h and adequately anesthetized before the procedure. They were 
then laid down at a slight incline in a supine position. Since water is able to provide 
acoustic couple, the esophagi were filled with water; following which the endo-
scopic probe was inserted through the mouth and advanced using gentle force, 
until it could no longer be advanced gently (25–30 cm). At this point, simultaneous 
PA and US imaging were initiated and images were acquired. Following in vivo 
imaging, the rabbits were euthanized, and their esophagi were imaged again in an 
ex vivo setting, using the same procedure. On completion of the ex vivo imaging, 
samples were collected for histology, and the results were later compared with the 
PA and US images.
In vivo imaging results: cross-sectional PA images and corresponding coregistered 
US images of vasculature within the esophagi were acquired. Since the images were 
acquired over several respiration cycles, they had significant motion artifact, which 
resulted in an uneven mapping of the vasculature. With assistance from a filter-
ing algorithm and at the expense of spatial resolution, the motion artifacts were 
artificially corrected. Ultimately, only larger vascular structures and organs like 
Figure 6. 
(A and B) Photos of the catheter-based PA and US probe within the 3.7 mm channel of a clinical video 
endoscope. (C and D) Side-viewing design of distal end of the combined probe. (E and G) Normalized PA 
images of rabbit esophagus show the total Hb distribution in vivo and ex vivo, correspondingly. The left side is 
the lower esophagus; the right side is the upper esophagus. (F and H) Total Hb distribution in the mediastina 
in vivo and ex vivo, correspondingly. AO, aorta; TC, trachea; AL, accessory lobe; LL, left lobe; RL, right lobe; 
CA, carina; CVC, caudal vena cava; LBV1, 2, large blood vessels; CC, cricoid cartilage. Scale bar, 10 mm.  
(I and J) B-scan images PA (red) and US (green) as indicated at E, F: esophageal wall (EW) is less contrasted 
on US image than on PA image. The images are reproduced from open-source publication [30] with author 
permission.
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the inferior vena cava, aorta, and parts of the pulmonary vasculature were visible. 
Unfortunately, following the correction, the finer vessels were blurred out and were 
not visible.
Ex vivo imaging results: the absence of motion artifact in the ex vivo experiments 
enabled the acquisition of higher-quality, uninterrupted 3-D maps of the esopha-
geal vasculature. The PA data was clearer, stronger, more detailed, and overall supe-
rior than the US data. Vascular structures (both major and feeding vessels) were 
clearly visible, whereas in US the smaller vessels were not as clear. Using PA, the 
group was also able to measure the blood vessel diameter, based on the PA esopha-
gus distance maps. On comparing PA and US images with histology, it was found 
that the PA images provided clear boundaries of the esophageal wall, consistently 
throughout the length of the esophagus. This can be attributed to a strong PA signal 
generated by the capillary dense submucosal layer. However, the US did not show 
clear boundaries of the mucosal and submucosal layers consistently, mainly due to 
weak signal intensities in these layers. Wall thickness of the esophagus calculated 
using PA varied only slightly from the histological images (PA were thinner than 
histological images). This slight change can be attributed to distortion of the tissue 
during histological fixation. Thorough analysis of PA-US overlapped images made it 
possible to identify the submucosal layer of the esophagus along with the surround-
ing vasculature like the aorta and inferior vena cava [30]. Thus, PAE can provide 
label-free visualization of microvasculature (as small as 190 μm), which exceeds the 
capability of current EUS technique in the esophagus. While Doppler ultrasonog-
raphy can image blood vessels, it can only image large blood vessels which lowers 
its sensitivity. Since PAE can image smaller blood vessels, it is far more sensitive 
and could prove to be an invaluable asset for diagnosing BE. Moreover, PAE can 
also visualize vasculature in the surrounding mediastinal region, which can prove 
helpful intraoperatively (during esophagectomy). Since a majority of modern endo-
scopes have narrow working channels, further miniaturization of the tool to about 
2.8 mm in diameter is required. Furthermore, if motion artifacts can be decreased, 
this technique can be used not only for diagnosing BE but also for guiding surgical 
procedures like esophagectomy. Motion artifacts can be reduced by increasing the 
scanning speed and by adding respiratory gating to the image acquisition. Next, we 
will talk about an ex vivo study that was done in human samples.
2.1.3 Ex vivo endoscopic resection tissue with PA tomography system
An ex vivo feasibility study in humans that used PA imaging in patients 
undergoing EMR for dysplasia was conducted by Lim et al. [31]. The aim of this 
study was to identify microvascular patterns associated with dysplasia in ex vivo 
samples, with the long-term goal of performing in vivo PA imaging for the detec-
tion of dysplasia in patients. In this study, a commercially available photoacoustic 
tomography imaging system Vevo LAZR (VisualSonics, Toronto, Ontario, Canada) 
was applied. A linear-array US transducer of 40 MHz central acoustic frequency 
and 256 elements (LZ550, VisualSonics) were integrated with fiber-optical bundles 
to provide a cross-laser-beam geometry for optical excitation. Photoacoustic and 
US images were recorded and displayed at a frame rate of 5 Hz. PA and US scans 
were obtained from a total of 13 ex vivo EMR samples from 8 patients. Excised 
tissues were mounted using ultrasound gel onto a plastic dish filled with gelatin 
(5% weight of 40 mL volume) to minimize acoustic signals from the dish. Because 
of the cross-laser-beam geometry of the PA imager fiber bundle attached to the 
transducer, there was an optimal photoacoustic zone located between 9 and 11 mm 
in front of the probe. Hence, they positioned the top surface of the tissue at 9 mm 
for consistency between samples.
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PA imaging scans were made at each wavelength of 680, 750, and 850 nm. 
Additional measurements were made at 824 and 970 nm in anticipation of future 
work, in which this data would serve as controls in studies of topical biomarker-
targeted porphyrin-lipid nanoparticle contrast. The transducer was mounted onto a 
motorized translational stage and scanned over a 3D volume at ~0.06 mm step size. 
The PA imaging laser power was below the ANSI maximum permissible exposure 
for skin (20–70 mJ/cm2 for 680–970 nm), avoiding any tissue heating that might 
damage the tissue, as confirmed on subsequent histopathology. Once data acquisi-
tion was completed, the specimen was marked and sent for histopathology.
The relative concentrations of oxyhemoglobin (HbO2) and deoxyhemoglobin 
(Hb) were estimated by PA imaging intensity using two wavelengths of 750 nm and 
850 nm. The relative total hemoglobin was then given by the sum of relative HbO2 
and Hb values. PA images were used for a 3D reconstruct of the complete EMR 
tissue. The US provided structural information, while the PA imaging provided 
functional information about the distribution of endogenous absorbers (blood) 
within the tissue. While there were no differences seen relative hemoglobin (HbT) 
among the various subclasses of BE, a higher relative HBt was seen in BE as com-
pared to normal squamous mucosa. Since BE is associated with increased vascu-
lature, it makes sense that it appears salmon pink under WLE (whereas normal 
tissue appears white). Even though this study did not utilize submucosal tissue, PA 
imaging data was detected beyond 2 mm from the tissue surface. A major limitation 
of this study was that distinction between dysplastic BE and nondysplastic BE could 
not be made on resected tissue. Further studies are needed to find out if PA imaging 
can help detect dysplasia. However, owing to its penetration depth capability, PA 
imaging can be very useful for endoscopic cancer staging. Note that the selection of 
more optimal PA imaging system also can improve the outcome.
2.2 Inflammatory bowel diseases
Inflammatory bowel disease (IBD) is widely prevalent and carries a significant 
burden around the world [32]. While the diagnosis is usually a clinical one, colo-
noscopy is performed for confirmation. Patients with a long-standing history of 
the disease (8–10 years) are at a higher risk of developing colorectal cancer. Annual 
screening colonoscopies are advised to detect early cancer changes (dysplasia) and 
to monitor the status of the disease in these patients. Colonoscopy is a minimally 
invasive but uncomfortable procedure that is necessary in this patient population. 
Real-time multispectral optoacoustic tomography (MSOT) imagers can detect the 
oxygenated and deoxygenated hemoglobin in tissue, thereby allowing physicians to 
detect structural and vascular changes associated with IBD in a noninvasive man-
ner. More recently, MSOT can use combined photoacoustic and ultrasound signals, 
which further improves its radiologic capabilities. In this section we will discuss 
three studies that used MSOT to study IBD. First, we will talk about a preclinical 
study that used MSOT to study inflammatory and early cancer changes associated 
with IBD, in mice.
2.2.1 Preclinical studies
Bhutiani et al. [33] tested the usefulness of this MSOT to assess inflammatory 
and dysplastic changes associated with IBD, in bowel murine models. The goal of 
the study was to assess diagnostic capability of PA imaging of endogenous contrast 
agent (hemoglobin) for inflammation of the GI tract organs in preclinical model. 
A total of 9 mice were imaged from the thorax to the pelvis using the preclinical 
MSOT system inVision 256 TF (iThera Medical). Wavelengths of 680, 710, 730, 
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740, 760, 770, 780, 800, 850, and 900 with an acquisition time of 10 ms per frame 
were used for imaging. Imaging was done at three time points, the first one was 
before bacterial inoculation, the second one was done 2 days post bacterial inocula-
tion, and the final imaging was done 7 days post bacterial inoculation. The images 
were reconstructed through back projection with 75 μm resolution. Following 
imaging, colonoscopy was performed on the mice, and a Colitis Severity score was 
obtained using a standard severity index. After colonoscopy, the mice were eutha-
nized, and samples from their colons were taken and sent for histopathology.
The mice in the experimental group, who had bacterial-induced colitis, showed 
an increased mesenteric and colonic vascularity. An increase in the mean signal 
intensity of oxygenated hemoglobin by MSOT was also observed in the experimen-
tal group as compared to the control group. The intensity of the signal was mild at 
time point two (i.e., 2 days post bacterial inoculation) and was most remarkable 
at point three (i.e., 7 days post bacterial inoculation). The deoxygenated signal 
obtained through MSOT showed no difference between the two groups at any time 
point. The findings on MSOT were confirmed by the colonoscopy findings. The 
mice in the experimental group, who had bacterial-induced colitis, had higher 
colitis score than the control group at time point two (2.5 vs. 1.5). At time point 
three, i.e., 7 days post bacterial inoculation, the experimental group had an average 
score of 5.5 with visible vascular and structural changes. Both the MSOT and colo-
noscopy findings were also confirmed by histopathology. Mice in the experimental 
group showed increased infiltration by inflammatory cells along with architectural 
destruction, at both time points two and three. We will now discuss two clini-
cal models that used MSOT to assess changes associated with Crohn’s disease in 
humans.
2.2.2 Clinical studies
Using clinical, handheld probe MSOT, intestinal inflammation in 91 patients 
with Crohn’s disease (ClinicalTrials.gov number, NCT02622139) was detected 
transabdominally as reported by Knieling et al. [34]. MSOT was used to assess 
hemoglobin levels in the intestinal walls of patients with active and non-active 
Crohn’s disease. Using clinical, endoscopic, and histological scorings, patients were 
classified into two groups: patients who had active Crohn’s disease (inflammation) 
and patients with no active disease (no inflammation). Ultrasonography was also 
done, following which the patients underwent MSOT imaging. Comparisons were 
made between the distributions of MSOT measurements between the two groups 
(patients with active Crohn’s vs. non-active disease). The diagnostic performance 
of MSOT was also compared with that of ultrasonography. It was found that there 
was a significant difference in single wavelength measurements at 760 nm and 
spectrally unmixed total hemoglobin between patients in remission and those with 
active disease. While this study was limited by a small sample size, it suggests that 
MSOT can be used to differentiate patients in remission from those with the active 
disease. If patients are in remission, they do not need more invasive procedures 
(Figure 7).
In another set of experiments conducted by Waldner et al. [35], as a part of the 
same clinical trial (ClinicalTrials.gov number, NCT02622139), MSOT was used as 
rapid, noninvasive method to assess disease activity in patients with Crohn’s disease. 
CD activity was determined based on clinical, endoscopic, and histologic evaluation 
along with ultrasonography. A handheld MSOT device (3–4 MHz, 256 transducer) 
was placed on the abdominal wall and used to provide images of the intraabdominal 
organs. B-mode ultrasound imaging was used in conjunction to localize parts of the 
intestine for accurate photoacoustic measurements.
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MSOT signals were acquired with 700-, 730-, 760-, 800-, 850-, and 900-nm 
excitation wavelengths. Results showed that Hbtotal, HbO2, and SO2 continuously 
increased and correlated well with disease activity. Since MSOT signals can be 
obtained within 5 minutes, this technique can be used as a rapid, noninvasive way 
to assess disease activity in patients with Crohn’s disease.
MSOT offers many advantages over the current imaging modalities. It is portable 
and noninvasive with a high depth of tissue penetration (up to 5 cm). It does not 
Figure 7. 
Multispectral photoacoustic tomography for the assessment of Crohn’s disease activity. (A) Transabdominal imaging 
method using handheld US probe upgraded with laser light illuminators. PA data were acquired at the wavelengths 
of 700, 730, 760, 800, 850, and 900 nm. MSOT system calculated total hemoglobin (Hbtotal), oxygenated 
hemoglobin, deoxygenated hemoglobin, and oxygen saturation to evaluate tissue perfusion and oxygenation as 
factors of inflammation. (B) Normalized signal level indicated Hbtotal in the intestinal wall of both the large bowel 
and the small intestine as a function of endoscopic inflammation degree. Simplified endoscopic score for Crohn’s 
disease (0–56) was applied to evaluate severity of intestinal inflammation: Remission <3; low disease activity 3–6; 
moderate disease activity 7–15; high disease activity >16. IQR is the interquartile range; a single asterisk points to 
P < 0.05 and a double one to P < 0.001. (C) The top row represents pseudocolored maps of Hbtotal in the large bowel 
and small intestine with an overlay of US images. The middle row exhibits schematics of the top row images. The 
bottom row demonstrates the corresponding endoscopic images used for evaluation of inflammation. The images are 
reproduced from [34]. Copyright © 2017 Massachusetts medical society. All rights reserved.
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require contrast agents and quantifies oxygenated hemoglobin, to inform physicians 
about inflammatory and vascular changes associated with IBD. Therefore, it can be 
used as a noninvasive objective assessment tool not only to diagnose IBD but to also 
monitor its severity, progression, and transformation into cancer. Small changes in 
MSOT imaging can prompt physicians to alter treatment course and possibly also 
help with early detection of cancer. Finally, since it is noninvasive and less uncom-
fortable than a colonoscopy, it is also likely to be accepted by patients.
2.3 Pancreatic cancer
Pancreatic cancer is the seventh leading cause of cancer-related mortality world-
wide [36]. The 5-year survival rates are <7%, mostly due to a delayed diagnosis and 
ineffective treatment methods [37]. Treatment is usually done by surgical resection 
of the tumor, and only 20% of patients are eligible for resection at their initial diag-
nosis, due to locoregional spread and metastasis [38]. The 5-year survival rates can 
be significantly improved if the diagnosis is made at an early stage (no metastasis) 
and if the patient has cancer-free margins post-surgery [39, 40]. When the diagno-
sis is made at an early stage, the tumor is usually small, well defined, and localized. 
During surgical resection of the tumor, the surgeon aims to remove the entire 
cancerous tissue (to get cancer-free margins); however, margin-positive resections 
occur very frequently (up to 70% of PDAC cases) [41]. Due to the growth pattern of 
the tumor and inability to differentiate between normal and cancerous tissue, small 
tumor extensions are usually missed during surgery. This increases the chances of 
metastasis post-surgery which impacts long-term survival rates negatively.
The current imaging modalities used for diagnosis and treatment are X-ray 
radiography, transabdominal ultrasound, endoscopic ultrasound, computed tomog-
raphy, magnetic resonance imaging (MRI), positron emission tomography (PET), 
and single-photon emission computed tomography (SPECT). While sensitivity for 
detecting tumors larger than 2 cm is very high with modalities like CT, the sensitiv-
ity for tumors less than 2 cm is only 77% [42]. Imaging techniques like ultrasound, 
CT, and MRI detect structural and anatomical changes in the pancreas. They cannot 
detect molecular changes, and since it takes years of molecular changes for the 
structural changes to manifest, these imaging techniques have low specificity for 
early detection of pancreatic cancer. Molecular imaging techniques like PET and 
SPECT offer more sensitivity and specificity. But PET and SPECT involve ionizing 
radiation and thus are harmful to living organisms. Another major limitation of 
the conventional imaging techniques is that most of them cannot be employed as 
intraoperative imaging tools [43].
The only tools currently available intraoperatively to assist the surgeon 
with resection are intraoperative ultrasound (IOUS) and intraoperative frozen 
section analysis (IFSA) by a pathologist. IOUS helps the surgeon to anatomi-
cally differentiate cancerous tissue from the surrounding structures [44, 45]. It 
provides high-resolution, real-time intraoperative imaging and helps determine 
resectability of the tumor [44]. However, it is not as reliable for detecting smaller 
superficial lesions [46]. Additionally, it requires considerable amount of training 
and experience both for operation and for interpretation [47]. IFSA also helps 
determine resectability of the tumor, when locoregional spread is identified. It 
helps the surgeon to ensure negative margins after resection [48]. However, it 
is time-consuming and associated with high false-negative results [49, 50]. The 
inability to accurately identify tumors intraoperatively can lead to incomplete 
resections, which results in metastasis post-surgery. Additionally, patients with 
undetectable micrometastasis, who are not eligible for resection, may undergo 
unnecessary surgeries without any impact on the outcome. Thus, there is a need for 
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newer imaging techniques that can help with early detection pf pancreatic cancer 
and also help stratify patients better for treatment. Since PA imaging combines the 
use of light and sound waves, it can provide real-time, high-resolution, functional, 
and molecular imaging without ionizing radiation—a significant advantage over 
the other imaging techniques like CT, PET, and US. As previously discussed, PA 
imaging also allows penetration up to clinically relevant depths, thereby making 
it a favorable imaging tool that can be used intraoperatively. Additionally, when 
used in conjunction with tumor-targeting molecular agents, it has the potential to 
provide crucial information to the surgeon during intraoperative use. Lastly, PA 
imaging is very complimentary both to US imaging and fluorescence imaging and 
can be easily adopted by gastroenterologists.
2.3.1 Preclinical studies on diagnostics
Using exogenous agents in PA imaging can further enhance its diagnostic 
capabilities. Homan et al. [51] developed a PA contrast agent—silver-silica nano-
cages (180–520 nm in diameter), to enhance PA imaging in pancreatic tissue. The 
nanocages were injected into the ex vivo porcine pancreas which were then imaged 
using a combined PA and US benchtop experimental setup (PA-US). The PA-US 
used an 800 nm light with a 7 ns pulse duration at a 10 Hz repetition rate. Optical 
fibers were symmetrically bundled on two sides of the US linear transducer array 
with 7 MHz center frequency, 14 mm wide, and 128 channels, and this arrangement 
allowed to produce PA and US images along the same plane. The imaging results 
showed that nanocage contrast agents enhanced PA imaging contrast.
Further, Homan et al. [52] also used silver nanoplates as PA imaging contrast 
agent to conduct in vivo PA and US imaging in transgenic mice with orthotopically 
grown pancreatic cancer. At first, PA and US images of the tumor were obtained 
without the nanoplates. Subsequently, silver nanoplates were injected into the tail 
vein, and imaging was done every hour following the injection, up to a total of 6 h. 
PA signals were captured in the wavelengths of 740–940 nm to differentiate the sig-
nals from blood and nanoplates using known optical spectra. A 3-D reconstruction 
of the orthoptic tumor was made, and a heterogenous distribution of nanoparticle 
accumulation in the tumor was noted. These findings were confirmed on histology. 
Because silver nanoparticles accumulate in the tumor and can provide contrast-rich 
images of the tumor using PA imaging, they have tremendous potential particularly 
in studying the molecular profile of pancreatic cancer.
Dai et al. [53] conducted a study in which they used in vivo murine models to 
obtain molecular images of pancreatic tumor at transmission (forward projection) 
mode of PA imaging. They used multimodal endoscopic approach combined with 
targeted multifunctional iron oxide nanoparticles (IONPs). The authors evaluated 
the efficiency of the proposed biomarkers to identify margins of pancreatic tumor 
using contrasted PA imaging and compared to NIR fluorescence. Results showed 
that the contrast between the tumor and normal tissue was very low to identify the 
tumor with nontargeted molecules (NIR830-IONP), whereas tissue with targeted 
molecules (NIR830-ATF-PEG-IONP) showed greater contrast between normal and 
cancerous tissue. Additionally, the tumor margins were clearly demarcated. The use 
of targeted multifunctional nanoparticles significantly improved the signals of the 
tumor.
2.3.2 Clinical studies on intraoperative photoacoustic imaging
An intraoperative use of PA imaging that targets the epidermal growth factor 
receptor (EGFR) was described by Tummers et al. [54]. EGFR a transmembrane 
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receptor is highly expressed in pancreatic cancer and hence can be used as a 
target for fluorescence imaging. Patients with pancreatic cancer, who were 
eligible for resection, were given a pretreatment dose of unlabeled cetuximab, 
which saturated the EGFR receptors in normal tissue with high expression. 
This also helped differentiate between a cetuximab reaction and a cetuximab-
IRDye800 reaction. Thereafter, patients underwent surgery. During surgery, 
the abdomen was first imaged using laparoscopic optical imaging system (NIR 
imaging), which was followed by resection of tumor. Following resection, all 
excised tissues underwent ex vivo photoacoustic imaging. Lastly, the samples 
were sent for histopathological correlation. Results showed that during laparo-
scopic NIR imaging, the pancreatic tumor and lymph nodes would be identi-
fied in all patients (6/6). Using fluorescence imaging, a clear contrast was seen 
between the tumor and surrounding tissue for pancreatic cancer and lymph node 
dissection. Ex vivo photoacoustic images showed an increased PA signal in the 
primary tumor tissue as compared with the surrounding pancreatic tissue and in 
tumor-bearing LN. A difference in signal-to-noise ratio was also observed. Both 
these findings were consistent with the fluorescence imaging results in the same 
patients.
Figure 8. 
(A) Absorption spectrum detected with UV-VIS spectrophotometer when light is attenuated only via molecular 
absorption. (B) UV-VIS spectrum when light is attenuated (i) due to molecular absorption by contrast 
nanoagents after its cellular uptake and (ii) a part of the incident photon flux is scattered. (C and D) 
absorption spectra of PEG-coated gold nanoparticles localized in extracellular matrix (HUVEC+GNRout) 
and internalized by HUVEC cells (HUVEC+GNRin) as detected by all-optical, narrow-beam PA 
spectrophotometer. Reproduced from open-source publication [22].
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2.3.3 Identifying photoacoustic properties of target nanoagents in complex media
The future work on the detection and treatment of pancreatic cancer with PA 
will include investigation of theranostic nanoagents that have potential to provide 
specific molecular-targeted PA imaging of malignant tumor, PA and US activation 
of nanoagents, and following treatment of lesions.
Photoacoustic properties include (a) thermoelastic behavior of a system of an 
absorbing compound in complex surrounding environment and (b) absorption 
spectrum of nanoagents involved in biological processes. Petrova et al. [55] dem-
onstrated that generation of PA response from blood in terms of its thermoelastic 
properties depends on compartmentalization of hemoglobin within erythrocyte. 
Recently, Pelivanov et al. [22] showed that localization of nanoagents in extracel-
lular and/or intracellular matrix can affect the resultant absorption spectrum of 
nanoagents (Figure 8).
To identify thermoelastic and optical properties of PA contrast agents meticu-
lously is crucial for successful implementation of theranostic nanoparticles for the 
therapy and early diagnostics of pancreatic cancer.
3. Conclusions
In summary, PA imaging is an emerging modality in gastroenterology and 
mostly used in combination with ultrasound or fluorescent imaging. Diagnosis 
through angiogenesis and blood oxygenation in the lining of esophagus and colon 
can be performed using PA imaging. High-resolution, multispectral PA imaging is 
offered via catheter-based (i) all-optical/noncontact solution and (ii) a miniatur-
ized contact PA/US endoscope for preclinical studies. The capability to image both 
the mucosa and submucosa layers (up to 3–4 mm in depth of GI tract walls) is the 
vast advantage of these PA methods comparing to other routinely used optical 
imaging modalities. However, further miniaturization of catheter-based endo-
scopes and improvement on specificity of diagnostics through blood oxygenation 
parameters are required. Multispectral, multiscale PA/US system based on hand-
held probe demonstrated rigorous data on assessment of a chronic inflammatory 
bowel disease in clinical studies. Using multispectral transabdominal examina-
tion, the PA system was able to evaluate hemoglobin level and blood oxygenation 
and accurately correlate it with abnormal activities in the large bowel and small 
intestine assessed through standard colonoscopic procedure. The only limitation 
of this method is depth beyond 5–6 cm in the body. Nonetheless, the proposed PA 
approach is noninvasive and use non-ionized radiation that is extremely fascinating 
for further clinical research. Many other PA imaging methods including intraopera-
tive multimodality of PA and fluorescent imaging are currently under development 
and demonstrate high potential for use in gastroenterology.
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